Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Recruiting

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

NCT06027853

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Clinical research ethics committee of the first affiliated hospital, college of medicine, zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT06006403

Conditions: Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), +16 more
Locations: Shanxi Bethune Hospital Taiyuan, Shanxi, China

View Trial Details

Recruiting

Acute Myeloid Leukemia Registry

NCT05979675

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Antalya Training and Research Hospital Antalya, Turkey (Türkiye)

View Trial Details

Recruiting

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

NCT05909293

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML

NCT05805098

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Qiu Huiying Suzhou, Jiangsu, China

View Trial Details

Recruiting

A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia

NCT05736965

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Changzhou Municipal No.1 People's Hospital Changzhou, China

Sichuan Provincial People's Hospital Chengdu, China

Jilin University China Japan Union Hospital Ch’ang-ch’un, China

Harbin Institute of Hematology and Oncology Ha’erbin, China

View all 19 locations

View Trial Details

Recruiting

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

NCT05367700

Conditions: Bone Marrow Diseases, CML, Accelerated Phase, CML, Chronic Phase, +14 more
Locations: Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT

NCT05682755

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML

NCT05584761

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia-2, +13 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission

NCT05404906

Conditions: Acute Myeloid Leukemia (AML) in Remission, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, Jiangsu, China

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions